Stockscreener 앱 받기
2.29
6.53%
-0.16
전일 마감가:
$2.45
열려 있는:
$2.47
하루 거래량:
129.90K
Relative Volume:
0.48
시가총액:
$47.84M
수익:
-
순이익/손실:
$-94.11M
주가수익비율:
-0.381
EPS:
-6.01
순현금흐름:
$-86.06M
1주 성능:
-1.29%
1개월 성능:
-4.58%
6개월 성능:
-46.74%
1년 성능:
-66.91%
1일 변동 폭
$2.28
$2.565
1주일 범위
$2.28
$2.58
52주 변동 폭
$1.78
$8.56
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
명칭
Adverum Biotechnologies Inc
전화
(650) 649-1004
주소
100 CARDINAL WAY, REDWOOD CITY, CA
ADVM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
2.29 | 52.64M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-25 | 개시 | Oppenheimer | Outperform |
| 2024-04-30 | 개시 | H.C. Wainwright | Buy |
| 2022-07-07 | 업그레이드 | Truist | Hold → Buy |
| 2021-07-23 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | 다운그레이드 | Truist | Buy → Hold |
| 2020-12-16 | 개시 | UBS | Neutral |
| 2020-11-12 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | 개시 | RBC Capital Mkts | Outperform |
| 2020-05-05 | 업그레이드 | SunTrust | Hold → Buy |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-03-16 | 개시 | SVB Leerink | Outperform |
| 2020-02-10 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | 업그레이드 | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-09-13 | 재확인 | Chardan Capital Markets | Neutral |
| 2019-06-14 | 재개 | Raymond James | Mkt Perform |
| 2018-11-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | 다운그레이드 | SunTrust | Buy → Hold |
| 2018-09-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-08-30 | 개시 | SunTrust | Buy |
| 2018-02-15 | 재개 | Piper Jaffray | Overweight |
| 2017-10-12 | 개시 | Raymond James | Outperform |
모두보기
Adverum Biotechnologies Inc 주식(ADVM)의 최신 뉴스
Published on: 2025-08-11 03:29:27 - Newser
Technical signs of recovery in Adverum Biotechnologies Inc.5-Year Price Trend Summary and Analysis - Newser
Is Adverum Biotechnologies Inc. stock bottoming outReal Trader Watchlist with Entry Targets - Newser
What to do if you’re stuck in Adverum Biotechnologies Inc.High Confidence Strategy with Trend Alignment - Newser
Adverum Biotechnologies Inc. stock prediction for this weekChart Driven Opportunity Scanner with Alerts - Newser
Is Adverum Biotechnologies Inc. a candidate for recovery playMarket Opportunity Tracker for Swing Traders - Newser
What makes Adverum Biotechnologies Inc. stock price move sharplyPredictive Screener for Daily Trade Watch - Newser
Adverum Biotechnologies Inc expected to post a loss of $2.25 a shareEarnings Preview - TradingView
Adverum Biotechnologies shares fall 2.38% intraday after executives to participate in H.C. Wainwright 5th Annual Ophthalmology Virtual Conference. - AInvest
How to build a dashboard for Adverum Biotechnologies Inc. stockPredicted Market Direction Based on Momentum - Newser
Adverum Biotechnologies to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - GlobeNewswire
Adverum Leadership to Share Latest Ophthalmology Insights at H.C. Wainwright Conference - Stock Titan
How high can Adverum Biotechnologies Inc. stock price go in 2025Free Weekly Top Gainers Forecast Watchlist - Newser
What drives Adverum Biotechnologies Inc. stock priceStrong return on assets - Jammu Links News
What are analysts’ price targets for Adverum Biotechnologies Inc. in the next 12 monthsHigh-octane investment gains - Jammu Links News
How volatile is Adverum Biotechnologies Inc. stock compared to the marketGame-changing returns - Jammu Links News
Is Adverum Biotechnologies Inc. stock overvalued or undervaluedUnlock daily stock market insights for success - Jammu Links News
Should I hold or sell Adverum Biotechnologies Inc. stock in 2025Discover stock picks with superior returns - Jammu Links News
Is Adverum Biotechnologies Inc. a good long term investmentExplosive market performance - Jammu Links News
Pattern recognition hints at Adverum Biotechnologies Inc. upsideReal-Time Equity Price Action Analysis - newser.com
How does Adverum Biotechnologies Inc. generate profit in a changing economyHigh-yield market plays - Jammu Links News
Published on: 2025-08-03 12:31:10 - Jammu Links News
When is Adverum Biotechnologies Inc. stock expected to show significant growthHigh-octane financial growth - Jammu Links News
What are the latest earnings results for Adverum Biotechnologies Inc.Free Expert Stock Watchlist - Jammu Links News
What are Adverum Biotechnologies Inc. company’s key revenue driversBuild a diversified portfolio for risk management - Jammu Links News
What is the risk reward ratio of investing in Adverum Biotechnologies Inc. stockAchieve consistent profits with proven strategies - Jammu Links News
How many analysts rate Adverum Biotechnologies Inc. as a “Buy”Maximize returns with disciplined trading approaches - Jammu Links News
Why is Adverum Biotechnologies Inc. stock attracting strong analyst attentionRapidly expanding wealth - Jammu Links News
What indicators show strength in Adverum Biotechnologies Inc.Machine Learning Stock Movement Detector - Newser
Is this a good reentry point in Adverum Biotechnologies Inc.Weekly Movement Forecast With Chart Signals - Newser
Is it the right time to buy Adverum Biotechnologies Inc. stockPre Market Planner For Beginners - jammulinksnews.com
Published on: 2025-07-31 02:50:15 - Newser
Adverum Biotechnologies Inc (ADVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):